Skip to main content

Table 1 Baseline characteristics of the study population, Tehran Lipid and Glucose Study (1999–2018)

From: Sex differences in the association between diabetes and hypertension and the risk of stroke: cohort of the Tehran Lipid and Glucose Study

  Men (n = 2446) Women (n = 2903) P value
Age, year 55.2 (10.5) 52.9 (9.2)  < 0.001
SBP, mmHg 125.9 (20.8) 127.6 (21.3) 0.005
DBP, mmHg 79.4 (11.9) 80.9 (11.1)  < 0.001
FPG, mmol/L 5.8 (1.9) 5.9 (2.4)  < 0.001
BMI, kg/m2 26.2 (3.9) 29.2 (4.6)  < 0.001
TC, mmol/L 5.4 (1.1) 6.0 (1.2)  < 0.001
Blood pressure status (%)    
 No hypertension 834 (34.1) 812 (28.0)  < 0.001
 Pre-hypertension 836 (34.2) 963 (33.2)
 Hypertension 776 (31.7) 1128 (38.9)
Glucose tolerance status (%)    
 No diabetes 1596 (65.2) 1839 (63.3) 0.013
 Pre-diabetes 528 (21.6) 599 (20.6)
 Type 2 diabetes 322 (13.2) 465 (16.0)
Smoking status (%)     < 0.001
 Past and never 1744 (71.3) 2778 (95.7)  < 0.001
 Current 702 (28.7) 125 (4.3)
Education level (%)    
 < 6 years 1040 (42.5) 1927 (66.4)  < 0.001
 6–12 years 1051 (43.0) 857 (29.5)
 > 12 years 355 (14.5) 119 (4.1)
Drug use (%)    
 Antihypertensive drugs 216 (8.8) 515 (17.7)  < 0.001
 Lipid lowering drugs 80 (3.3) 220 (7.6)  < 0.001
 Anti-diabetes drugs 146 (6.0) 263 (9.1)  < 0.001
Family history of CVD (%) 339 (13.9) 558 (19.2)  < 0.001
History of CHD (%) 210 (8.6) 175 (6.0)  < 0.001
  1. Data are shown as mean ± standard deviation (SD) or number (percent) and numbers (percentage) as appropriate
  2. SBP systolic blood pressure; DBP diastolic blood pressure; BMI body mass index; FPG fasting plasma glucose; TC total cholesterol; CVD cardiovascular diseases; CHD coronary heart disease